Distinguishing Supraventricular Tachycardia from Ventricular Tachycardia

Introduction to Diagnosis

• When faced with a wide-complex tachycardia, particularly in a patient with prior myocardial infarction, the American College of Cardiology recommends presuming ventricular tachycardia until proven otherwise and treating accordingly, as giving calcium channel blockers or verapamil for presumed SVT when VT is actually present can cause hemodynamic collapse and death 1, 2, 3, 4

Critical Clinical Context

• A history of previous myocardial infarction has a positive predictive value >95% for VT, making this the single most important clinical factor in the differential diagnosis, according to the American College of Cardiology 5, 6
• The first occurrence of wide QRS tachycardia after MI strongly indicates VT, as stated by the American College of Cardiology 7, 5, 3

ECG Differentiation

• Narrow QRS tachycardia is supraventricular in origin and includes AVNRT, AVRT, atrial tachycardia, atrial flutter, and atrial fibrillation, as noted by the American College of Cardiology 1, 2
• Pseudo R' wave in V1 and pseudo S wave in inferior leads are pathognomonic for AVNRT, according to the American College of Cardiology 1
• P wave in ST segment separated from QRS by >70 ms suggests AVRT, as stated by the American College of Cardiology 1

Definitive ECG Criteria for VT

• AV dissociation with ventricular rate faster than atrial rate proves VT but is only visible in 30% of cases, as noted by the American College of Cardiology 1, 7, 5, 6, 3
• Fusion complexes (represent merger of conducted supraventricular impulses with ventricular depolarization) are pathognomonic for VT, according to the American College of Cardiology 1, 7, 5, 6

Acute Management Algorithm

• Immediate synchronized DC cardioversion is the only appropriate intervention for hemodynamically unstable patients, with a Class I recommendation from the American College of Cardiology 7, 5, 6, 3, 4
• For hemodynamically stable patients with narrow QRS, first-line treatment is vagal maneuvers, followed by adenosine, according to the American College of Cardiology 7, 5, 6
• For hemodynamically stable patients with wide QRS of uncertain etiology, treat as VT if you cannot definitively prove SVT, as recommended by the American College of Cardiology 7, 5, 6, 3, 4

Critical Pitfalls to Avoid

• The most dangerous error is giving calcium channel blockers (verapamil/diltiazem) for wide-complex tachycardia that turns out to be VT, which precipitates hemodynamic collapse, as warned by the American College of Cardiology 1, 2, 3, 4
• Do not use adenosine in wide-complex tachycardia of uncertain etiology, as it can precipitate VF in patients with coronary disease and AF with rapid ventricular rate in pre-excited tachycardias, according to the American College of Cardiology 6, 3

Prognosis and Long-Term Management

• VT in the setting of prior MI carries significantly higher mortality risk and mandates ICU/CCU admission, immediate cardiology/electrophysiology consultation, consideration for ICD placement, and electrophysiology study for ablation consideration, as recommended by the American College of Cardiology 4, 6
• The presence of structural heart disease fundamentally changes prognosis—VT with prior MI represents substrate for sudden cardiac death, while most SVTs are benign from a mortality standpoint despite causing significant symptoms, according to the American College of Cardiology 2

Guideline Recommendations for Differentiating and Managing Ventricular Tachycardia

Clinical Context and Initial Suspicion

• In patients with a prior myocardial infarction, the first appearance of a wide‑complex tachycardia strongly suggests ventricular tachycardia (VT)【8】【9】.
• Prior myocardial infarction carries a >95 % positive predictive value for VT, making it the most important clinical clue in the differential diagnosis【8】.

ECG Criteria that Diagnose VT

Pathognomonic (Definitive) Features

• AV dissociation—ventricular rate faster than atrial rate—confirms VT, although it is observable in only about 30 % of cases【10】【8】.
• Fusion complexes (combined supraventricular and ventricular depolarization) are diagnostic for VT【8】.

Highly Specific (Suggestive) Features

• An RS interval >100 ms from the initial R wave to the nadir of the S wave in any precordial lead is highly specific for VT【8】.
• Negative concordance (all QS complexes) across the precordial leads is diagnostic for VT【8】.
• A QRS width >140 ms with a right‑bundle‑branch‑block (RBBB) pattern or >160 ms with a left‑bundle‑branch‑block (LBBB) pattern favors VT【9】.
• Presence of QR complexes indicates myocardial scar and occurs in roughly 40 % of VTs following myocardial infarction【8】.

Physical Examination Clues Supporting VT

• Irregular cannon “A” waves in the jugular venous pulse are associated with VT【9】.
• Variability in the intensity of the first heart sound may be observed in VT【9】.
• Fluctuating systolic blood pressure is another bedside indicator of VT【9】.

Acute Management of Hemodynamically Unstable Tachycardia

• For any patient who is hemodynamically unstable (e.g., syncope, cardiac arrest, severe hypotension, or angina), immediate synchronized DC cardioversion is the sole appropriate initial intervention【8】.

Management of Stable Narrow‑Complex Tachycardia

• First‑line therapy: Vagal maneuvers (Valsalva, carotid massage, facial immersion in cold water)【8】.
• Second‑line therapy: Intravenous adenosine if vagal maneuvers fail【8】.
  
  • Adenosine is preferred over calcium‑channel blockers because of its rapid onset and short half‑life【8].
  • It is contraindicated in patients with severe asthma【8].
  • Higher doses may be required in patients receiving theophylline, and its effects are potentiated by dipyridamole【8].

Management of Stable Wide‑Complex Tachycardia

• When the origin cannot be definitively proven as supraventricular, treat the rhythm as VT【8】.

Pharmacologic Cautions in Uncertain Wide‑Complex Tachycardia

• Adenosine should not be administered in wide‑complex tachycardia of uncertain etiology because it can precipitate ventricular fibrillation in patients with coronary artery disease and may induce atrial fibrillation with rapid ventricular response in pre‑excited tachycardias【8】.

Diagnostic Pitfalls

• QRS width and morphological criteria become less specific in patients receiving antiarrhythmic drugs, those with hyperkalemia, or severe heart failure【8】【9】.
• Atrial fibrillation with rapid ventricular response can be misidentified as regular SVT when the irregularity is subtle【10】.

Society attribution: All facts derived from citations in the American College of Cardiology (JACC) and the American Heart Association (Circulation).